J. Alanko

CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro.

Eeva Moilanen, J. Alanko, M Z Asmawi et al. · PubMed · 1988 · 56 citations

Pge2 Production, Arachidonic Acid Metabolism, Leukotriene B4 +17

Effects of antirheumatic drugs on leukotriene B4 and prostanoid synthesis in human polymorphonuclear leukocytesin vitro

Eeva Moilanen, J. Alanko, Erkki Seppälä et al. · Inflammation Research · 1988 · 36 citations

Inflammation, Anti-inflammatory, Leukotriene B4 +7

Adrenaline stimulates thromboxane and inhibits leukotriene synthesis in man.

J. Alanko, Asko Riutta, I. Muchá et al. · PubMed · 1992 · 28 citations

Inflammation, Adrenal Gland, Arachidonic Acid Metabolism +14

Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells.

Eeva Sievi, Tuula Lähteenmäki, J. Alanko et al. · PubMed · 1997 · 17 citations

Nitric Oxide, Pharmacotherapy, Oxidative Stress +16

Orally administered tolfenamic acid inhibits leukotriene synthesis in isolated human peripheral polymorphonuclear leukocytes

Eeva Moilanen, J. Alanko, A. Juhakoski et al. · Inflammation Research · 1989 · 16 citations

Inflammation, Anti-inflammatory, Oxysterol +7